Elsevier

Annals of Epidemiology

Volume 7, Issue 8, November 1997, Pages 568-574
Annals of Epidemiology

Original report
Risk of suicide attempts after benzodiazepine and/or antidepressant use

https://doi.org/10.1016/S1047-2797(97)00126-9Get rights and content

Abstract

PURPOSE: Recent publications imply the existence of associations between psychotropic drugs use and risk of suicide. Some studies have measured the tissue level of these drugs in suicide deaths, while others compared toxicity indices, defined as number of suicide deaths per million prescriptions for individual antidepressants. Few of these studies used unexposed controls. The objective of this cohort study was to evaluate suicide attempts in subjects recently exposed to benzodiazepines and/or antidepressants, as compared to unexposed controls.

METHODS: A population of 225,796 persons with prescriptions for benzodiazepines were selected from the Saskatchewan Health Data Bases. Controls consisted of 97,862 individuals who did not receive benzodiazepines.

RESULTS: Stratifying the populations into antidepressant users and non-antidepressant users indicated that nonantidepressant users had statistically significant associations between suicide attempts and benzodiazepine use (odds ratio (OR) = 6.2), antipsychotic use, (OR = 2.6), and a history of past treatment for drug/alcohol abuse (OR = 13.4). Antidepressant users showed a statistically significant relation only with past treatment for drug/alcohol use (OR = 5.8). It is argued that the large OR for antidepressant use is due to confounding by indication. If so, the concept of toxicity index is misleading and should not be used.

CONCLUSIONS: The association between benzodiazepine use and attempted suicide is especially high for nonantidepressant users, for the young, and for males. Whether this relationship is causal or not, physicians should be aware of the high potential for suicide attempts when prescribing benzodiazepines for patients in these high risk groups.

References (31)

  • G Isacsson et al.

    Antidepressants, depression and suicide: an analysis of the San Diego study

    J Affect Disord

    (1994)
  • CI Neutel

    Risk of traffic accident injury after a prescription for a benzodiazepine

    Annals of Epidemiol

    (1995)
  • G Isacsson et al.

    Use of antidepressants among people committing suicide in Sweden

    BMJ

    (1994)
  • G Isacsson et al.

    Low level of antidepressant prescription for people who alter commit suicide: 15 years of experience from a population-based drug database in Sweden

    Acta Psychiatr Scand

    (1992)
  • NA Buckley et al.

    Relative toxicity of benzodiazepines in overdose

    BMJ

    (1995)
  • JA Henry

    Toxicity of antidepressant: comparisons with fluoxetine

    Int Clin Psychopharmacol

    (1992)
  • WB Mendelson et al.

    Sedatives and suicide: the San Diego study

    Acta Psychiatr Scand

    (1993)
  • LE Derby et al.

    Antidepressant drugs and suicide

    J Clin Psychopharmacol

    (1992)
  • SS Jick et al.

    Antidepressants and suicide

    BMJ

    (1995)
  • S Kapur et al.

    Antidepressant medications and the relative risk of suicide attempts and suicide

    JAMA

    (1992)
  • JA Henry et al.

    Relative mortality from overdose of antidepressants

    BMJ

    (1995)
  • AA Nierenberg

    The medical consequences of the selection of an antidepressant

    J Clin Psychiatry

    (1992)
  • E Malcolm et al.

    Saskatchewan Health's linkable data bases and pharmacoepidemiology

    Post Marketing Surveill

    (1993)
  • CI Neutel et al.

    Medical events after a prescription for a benzodiazepine

    Pharmacoepidemiol Drug Safety

    (1995)
  • World Health Organization

    Manual of the international statistical classification of diseases, injuries, and causes of death

    (1977)
  • Cited by (80)

    • Association between opioid analgesic plus benzodiazepine use and death: A case-crossover study

      2020, Journal of Psychosomatic Research
      Citation Excerpt :

      Kim et al. reported that drug poisoning is the most common suicide attempt method among individuals aged 10–49 years than among those aged 70 years or more [56]. According to Neutel et al., suicide attempts using benzodiazepines increased and were especially high among younger individuals [57]. Since the causes of death were not included in our study, it remains unclear whether the high risk of death among young individuals was associated with suicide attempts.

    • Self-reported sleep disturbance in ambulance attendances for suicidal ideation and attempted suicide between 2012 and 2017

      2020, Journal of Affective Disorders
      Citation Excerpt :

      Despite this, a recent review concluded that use of benzodiazepines was associated with an increase in attempted suicides and suicidal behaviours (Dodds, 2017). A Canadian study reported that the risk of attempted suicide was high for both benzodiazepine use, and history of alcohol or drug treatment even after controlling for antidepressant use (Neutel and Patten, 1997). Strong positive associations between benzodiazepine use and suicide in elderly populations have previously been noted (Lodhi and Shah, 2004), with a Swedish study implicating benzodiazepines in 39% of drug-related suicides among people aged 65+ (Carlsten et al., 2003).

    • Suicidal ideation in a European Huntington's disease population

      2013, Journal of Affective Disorders
      Citation Excerpt :

      Also other unmeasured neuropsychiatric characteristics, like personality traits or coping styles, could be the reason for both more prevalent suicidal ideation and the use of benzodiazepines. Confounding by indication was considered the most likely explanation in a previous study that reported an association between benzodiazepine use and suicide attempts (Neutel and Patten, 1997). Although there was variance in suicidal ideation prevalences among countries, baseline suicidal ideation prevalences in the three largest participating countries (Germany, United Kingdom, and Poland) were around 8.0%.

    View all citing articles on Scopus

    Disclaimer: This study is based in part on data provided by the Saskatchewan Department of Health. The interpretation and conclusions contained herein do not necessarily represent those of the Government of Saskatchewan or the Saskatchewan Department of Health.

    View full text